Trxade Group to Present at Upcoming Investor Conferences in September
September 03 2020 - 4:15PM
Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement,
delivery and healthcare platform, will participate in the following
investor conferences during the month of September 2020: the
Colliers Institutional Investor Conference on September 10, 2020,
and the H.C. Wainwright 22nd Annual Global Investment Conference on
September 14-16, 2020.
Suren Ajjarapu, Chief Executive Officer of
Trxade Group, is scheduled to host a virtual presentation during
the H.C. Wainwright conference as follows and will participate in
one-on-one meetings throughout the day at both events.
2020 Colliers Institutional Investor
ConferenceDate: Thursday, September 10, 2020 Location:
Virtual
H.C. Wainwright 22nd Annual Global
Investment Conference Date: Wednesday, September 16, 2020
Time: 1:30 p.m. Eastern timeLocation: Virtual
For more information or to schedule a one-on-one
meeting with Trxade Group management, please contact your
conference representative, email your request to MEDS@mzgroup.us or
call Luke Zimmerman at (949) 259-4987.
About Trxade
Group, Inc.
Headquartered in Tampa, Florida, Trxade Group,
Inc. (Nasdaq: MEDS) is an integrated drug procurement,
delivery and healthcare platform that fosters price transparency,
thereby improving profit margins for both buyers and sellers of
pharmaceuticals. Trxade Group operates across all 50 states with
the central mission of making healthcare services affordable and
accessible. Founded in 2010, Trxade Group is comprised of three
synergistic operating platforms; (1) the Trxade B2B trading
platform with 11,725 registered pharmacies, (2) Integra Pharma
Solutions, Trxade Group’s virtual wholesale division, and (3) the
Bonum Health platform offering affordable telehealth services. For
additional information, please visit us at www.trxade.com and
www.bonumhealth.com.
Forward-Looking Statements
This press release may
contain forward-looking statements, including information about
management’s view of Trxade’s future expectations, plans and
prospects, within the safe harbor provisions under The Private
Securities Litigation Reform Act of 1995 (the “Act”). In
particular, when used in the preceding discussion, the words “may,”
“could,” “expect,” “intend,” “plan,” “seek,” “anticipate,”
“believe,” “estimate,” “predict,” “potential,” “continue,”
“likely,” “will,” “would” and variations of these terms and similar
expressions, or the negative of these terms or similar expressions
are intended to identify forward-looking statements within the
meaning of the Act, and are subject to the safe harbor created by
the Act. Any statements made in this news release other than those
of historical fact, about an action, event or development, are
forward-looking statements. These statements involve known and
unknown risks, uncertainties and other factors, which may cause the
results of Trxade, its divisions and concepts to be materially
different than those expressed or implied in such statements. These
risk factors and others are included from time to time in filings
made by Trxade with the Securities and Exchange Commission,
including, but not limited to, in the “Risk Factors” sections in
its Form 10-Ks and Form 10-Qs and in its Form 8-Ks, which it has
filed, and files from time to time, with the U.S. Securities and
Exchange Commission. These reports are available
at www.sec.gov. Other unknown or unpredictable factors also
could have material adverse effects on Trxade’s future results
and/or could cause our actual results and financial condition to
differ materially from those indicated in the forward-looking
statements. The forward-looking statements included in this press
release are made only as of the date hereof. Trxade cannot
guarantee future results, levels of activity, performance or
achievements. Accordingly, you should not place undue reliance on
these forward-looking statements. We undertake no obligation to
update publicly any of these forward-looking statements to reflect
actual results, new information or future events, changes in
assumptions or changes in other factors affecting forward-looking
statements, except to the extent required by applicable laws. If we
update one or more forward-looking statements, no inference should
be drawn that we will make additional updates with respect to those
or other forward-looking statements.
Investor Relations:
Luke Zimmerman Senior Vice President MZ Group - MZ North America
(949) 259-4987 MEDS@mzgroup.us www.mzgroup.us
TRxADE HEALTH (NASDAQ:MEDS)
Historical Stock Chart
From Mar 2024 to Apr 2024
TRxADE HEALTH (NASDAQ:MEDS)
Historical Stock Chart
From Apr 2023 to Apr 2024